Skip to content
Screener

Baxter International BAX Reportable Segment — European Medical Devices Regulation

Similar metrics at other companies

QuidelOrtho Corporation logo
QDELEU medical device regulation transition costs
$700K+250%
Alignment Healthcare logo
ALHCReportable Segment — Medical expenses
$1.09B+32.9%
Evolent Health, Inc. logo
EVHReportable segment — Medical expense and device costs
$493.02M+97.9%
Medtronic logo
MDTMedical Surgical — Reportable segment operating profit
$605M+5.2%
Rhythm Pharmaceuticals, Inc. logo
RYTMSingle reportable segment — Commercial & medical affairs
$20.26M+52.9%
Freshpet logo
FRPTReportable Segment — Media Costs
$40.81M+3.0%

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$14.13B+22.3%
Enterprise value$12.33B+22.1%
P/S1.3×+0.2×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept bax:EuropeanMedicalDevicesRegulationExpenses.

The source filing: Baxter International’s 10-K, filed February 12, 2026.

Filed
Feb 12, 2026, 4:46 PM EST
Fiscal year
FY2025
Accession
0001628280-26-007733
for the years ended December 31 (in millions)202520242023
Unallocated corporate costs(86)(275)(355)
Intangible asset amortization expense(598)(625)(590)
Business optimization items(178)(162)(174)
European Medical Devices Regulation(21)(33)(41)
Indefinite-lived asset impairments(290)(50)
Separation-related costs(58)
Legal matters(11)(17)(7)
Acquisition and integration items(27)(23)

Item 8. Financial Statements and Supplementary Data.

FAQ

What is Baxter International's reportable segment — european medical devices regulation?
Baxter International (BAX) reported reportable segment — european medical devices regulation of -$5.25M in Q4 2025.
How has Baxter International's reportable segment — european medical devices regulation changed year-over-year?
Baxter International's reportable segment — european medical devices regulation increased by 36.4% year-over-year, from -$8.25M to -$5.25M.
What is the long-term trend for Baxter International's reportable segment — european medical devices regulation?
Over 3 years (2022 to 2025), Baxter International's reportable segment — european medical devices regulation has grown at a -20.6% compound annual growth rate (CAGR), from -$42M to -$21M.
What does reportable segment — european medical devices regulation mean?
This represents the specific compliance and implementation costs associated with meeting the European Union's Medical Device Regulation (MDR) standards. These costs are necessary to maintain market access and ensure product safety within the European region.

Ask your AI about Baxter International's reportable segment — european medical devices regulation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude